Novo Nordisk

Invested through
  • Triodos Global Equities Impact Fund
  • Triodos Impact Mixed Fund - Defensive
  • Triodos Impact Mixed Fund - Neutral
  • Triodos Impact Mixed Fund - Offensive
Asset ClassesListed equity
Impact strategyImpact Equities and Bonds
Bloomberg tickerNOVOB DC
ISIN codeDK0060534915
Industry groupPharmaceuticals, Biotechnology & Life Sciences
Aligned with SDGs
  • Good health and well-being

* Additional information

Novo Nordisk develops, produces, and markets pharmaceutical products. The company focuses on diabetes care and offers insulin delivery systems and other diabetes products. Novo Nordisk also works in areas such as haemostatis management, growth disorders, and hormone replacement therapy. The Company offers educational and training materials. Novo Nordisk markets worldwide.